/Investor DB

Xcellerant Ventures — Full Portfolio

13 tracked investments · listed companies and verified rows first

Anuncia Medicalanunciamedical.com

Anuncia Medical develops medical technology focused on cerebrospinal fluid (CSF) science and clinical strategy to advance hydrocephalus treatment.

BiotechHealthtechMedical DevicesScottsdale, US

Darryl Baker(Executive Officer)Elsa Abruzzo(Executive Officer, Director)in

BoardDavid Donabedian(Director)Edgar D Janotta(Director)Stanton Rowe(Director)Stephen Oesterle(Director)

Co-investorsArieal Southeast Angel PartnersLongwood Fund

DeepLookdeeplookmedical.comin

DeepLook Medical develops DL Precise, an FDA-cleared medical imaging software that offers one-click segmentation and tumor morphology display across multiple modalities.

AI & Machine LearningDigital HealthHealthtechMedical DevicesNew Haven, US

Marissa Fayer(Chief Executive Officer)inDavid Dahn(Executive Officer)inGregory Belanger(Executive Officer, Director)Steve Schwadron(Executive Officer, Director)Ken Boulange(Executive Officer, Director)

BoardKarim Galzahr(Director)

Co-investorsAZ Venture Capital Inc.Bacchus Venture CapitalBoston Harbor AngelsCitrine AngelsEast Post Road VenturesIcebook Investments Corp.+3 more

Lenoss Medicallenoss.cominSeries A · Dec 2023 · $4M

Lenoss develops products aimed at advancing a physiological treatment pathway, supported by a team of industry professionals and clinical advisors.

BiotechHealthtechMedical DevicesProvidence, US

Dom Messerli, MBAinDominique Messerli(Executive Officer, Director)

Co-investorsAZ Venture Capital Inc.Beacon AngelsSlater Technology FundWalnut Venture Associates

Mindset Medicalmindsetmedical.comin

Mindset Medical develops medical-grade software that uses remote photoplethysmography (rPPG) and deep learning to measure vital signs such as heart rate and respiratory rate through the camera on a patient's own smartphone, tablet, or computer.

AI & Machine LearningDigital HealthHealthtechMedical DevicesPhoenix, US

Mark L. Whitehouse(Executive Officer)inMitchell A. Foster(Executive Officer, Director, Promoter)Nicholas Theodore(Director)Joel Barthelemy(Director)

BoardJAMES GOULKA(Director)inBRIAN BURNS(Director)in

Co-investorsGrayhawk CapitalAmgen VenturesAZ Venture Capital Inc.NOVA PrimeQuesta Capital

Rivia Healthriviahealth.cominFeb 2024

Rivia Health develops AI-powered patient payment automation software for specialty healthcare practices.

AI & Machine LearningEnterprise SoftwareHealthtechPhoenix, US

Rachel Mertensmeyer(Executive Officer, Director)inBrenda Schmidt(Director)

BoardGregg Scoresby(Director)in

Co-investorsAiSprouts VCDipalo VenturesEdge Case Capital PartnersMotley Fool VenturesPHX VenturesGolden Seeds

Simbiosyssimbiosys.comin𝕏

SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.

AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US

Joe Peterson(Co-founder)John Cole(Co-founder)Tushar Pandey(Co-founder)inStacey Stevens(Executive Officer, Director)in

BoardVikram Chaudhery(Director)inLucy Coassin(Director)

Co-investorsAV8 VenturesGenoa VenturesKleinmuntz AssociatesGENERAL INCEPTIONNorthpond Ventures

TruLite Healthtrulitehealth.comin

Trulite Health builds Truity, a health optimization platform that delivers clinical, social, and behavioral decision support and patient-facing nudges to providers and care teams at the point of care.

Digital HealthHealthtechSaaSTempe, US

Alan C. Roga(Executive Officer, Director)inJohn Barravecchia(Executive Officer)inShaung Liu(Executive Officer)in

BoardCaleb DesRosiers(Director)

Co-investorsOsage Venture PartnersService Provider CapitalInflect HealthOUP (Osage University Partners)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Deeplook MedicalGeneticureMu MedicalPortoTreatment Technologies and InsightsWave Health

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.